Nogal Bartek, McCoy Laura E, van Gils Marit J, Cottrell Christopher A, Voss James E, Andrabi Raiees, Pauthner Matthias, Liang Chi-Hui, Messmer Terrence, Nedellec Rebecca, Shin Mia, Turner Hannah L, Ozorowski Gabriel, Sanders Rogier W, Burton Dennis R, Ward Andrew B
Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Division of Infection and Immunity, University College London, London WC1E 6BT, UK.
Sci Adv. 2020 Jun 5;6(23):eaba0512. doi: 10.1126/sciadv.aba0512. eCollection 2020 Jun.
To date, immunization studies of rabbits with the BG505 SOSIP.664 HIV envelope glycoprotein trimers have revealed the 241/289 glycan hole as the dominant neutralizing antibody epitope. Here, we isolated monoclonal antibodies from a rabbit that did not exhibit glycan hole-dependent autologous serum neutralization. The antibodies did not compete with a previously isolated glycan hole-specific antibody but did compete with N332 glycan supersite broadly neutralizing antibodies. A 3.5-Å cryoEM structure of one of the antibodies in complex with the BG505 SOSIP.v5.2 trimer demonstrated that while the epitope recognized overlapped the N332 glycan supersite by contacting the GDIR motif at the base of V3, primary contacts were located in the variable V1 loop. These data suggest that strain-specific responses to V1 may interfere with broadly neutralizing responses to the N332 glycan supersite and vaccine immunogens may require engineering to minimize these off-target responses or steer them toward a more desirable pathway.
迄今为止,用BG505 SOSIP.664 HIV包膜糖蛋白三聚体对兔子进行的免疫研究表明,241/289聚糖空洞是主要的中和抗体表位。在此,我们从一只未表现出依赖聚糖空洞的自体血清中和作用的兔子中分离出单克隆抗体。这些抗体不与先前分离的聚糖空洞特异性抗体竞争,但确实与N332聚糖超位点广泛中和抗体竞争。一种抗体与BG505 SOSIP.v5.2三聚体复合物的3.5埃冷冻电镜结构表明,虽然识别的表位通过接触V3底部的GDIR基序与N332聚糖超位点重叠,但主要接触位于可变V1环中。这些数据表明,对V1的菌株特异性反应可能会干扰对N332聚糖超位点的广泛中和反应,疫苗免疫原可能需要进行工程改造,以尽量减少这些脱靶反应或将其导向更理想的途径。